Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 12, 2013, Pages

  Mamoulakis, Charalampos ^a   Sofras, Frank ^a   de la Rosette, Jean ^b   Omar, Muhammad Imran ^c   Lam, Thomas B L ^c   N'Dow, James M O ^d   Ubbink, Dirk T ^b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 85041748592     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009629.pub2     Document Type: Article

References (44)

1. Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J. Evaluation and treatment of lower urinary tract symptoms in older men. The Journal of Urology 2009;181(4):1779-87. [PUBMED: 19233402]
2. Acuña-López JA, Hernández-Torres AU, Gómez-Guerra LS, Martínez-Montelongo R, Lozano-Salinas JF. Bipolar versus monopolar transurethral resection of the prostate: intraoperative and postoperative result analysis. Revista Mexicana de Urología 2010;70(3):146-51.
3. Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al.Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. European Urology 2010;58(3):384-97. [PUBMED: 20825758]
4. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. [PUBMED: 21208779]
5. Burke N, Whelan JP, Goeree L, Hopkins RB, Campbell K, Goeree R, et al. Systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction. Urology 2010;75(5):1015-22. [PUBMED: 19854492]
6. Lower urinary tract symptoms: full guideline [CG97]. London: National Institute for Health and Clinical Excellence 2010.
7. Chen Q, Zhang L, Liu YJ, Lu JD, Wang GM. Bipolar transurethral resection in saline system versus traditional monopolar resection system in treating large-volume benign prostatic hyperplasia. Urologia Internationalis 2009;83(1):55-9. [PUBMED: 19641360]
8. Chen Q, Zhang L, Fan QL, Zhou J, Peng YB, Wang Z. Bipolar transurethral resection in saline vs traditional monopolar resection of the prostate: results of a randomized trial with a 2-year follow-up. British Journal of Urology International 2010;106(9):1339-43. [PUBMED: 20477825]
9. Djavan B, Nickel JC, de la Rosette J, Abrams P. The urologist view of BPH progression: results of an international survey. European Urology 2002;41(5):490-6. [PUBMED: 12074790]
10. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997;315(7109):629-34. [PUBMED: 9310563]
11. Fagerstrom T, Nyman CR, Hahn RG. Bipolar transurethral resection of the prostate causes less bleeding than the monopolar technique: a single-centre randomized trial of 202 patients. British Journal of Urology International 2010;105(11):1560-4. [PUBMED: 19912211]
12. Faul P, Schlenker B, Gratzke C, Stief CG, Reich O, Hahn RG. Clinical and technical aspects of bipolar transurethral prostate resection. Scandinavian Journal of Urology and Nephrology 2008;42(4):318-23. [PUBMED: 18622807]
13. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, GRADE Working Group. What is "quality of evidence" and why is it important to clinicians?. British Medical Journal 2008;336(7651):995-8. [PUBMED: 18456631]
14. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94. [PUBMED: 21195583]
15. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011;64(4):395-400. [PUBMED: 21194891]
16. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P, et al. GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). Journal of Clinical Epidemiology 2011;64(4):407-15. [PUBMED: 21247734]
17. Guyatt GH, Oxman AD, Montori V, Vist G, Kunz R, Brozek J, et al. GRADE guidelines: 5. Rating the quality of evidence-publication bias. Journal of Clinical Epidemiology 2011;64(12):1277-82. [PUBMED: 21802904]
18. Guyatt G, Oxman AD, Kunz R, Brozek J, Alonso-Coello P, Rind D, et al. GRADE guidelines 6. Rating the quality of evidence-imprecision. Journal of Clinical Epidemiology 2011;64(12):1283-93. [PUBMED: 21839614]
19. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 7. Rating the quality of evidence-inconsistency. Journal of Clinical Epidemiology 2011;64(12):1294-302. [PUBMED: 21803546]
20. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence-indirectness. Journal of Clinical Epidemiology 2011;64(12):1303-10. [PUBMED: 21802903]
21. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso-Coello P, et al. GRADE guidelines: 9. Rating up the quality of evidence. Journal of Clinical Epidemiology 2011;64(12):1311-6. [PUBMED: 21802902]
22. Hawary A, Mukhtar K, Sinclair A, Pearce I. Transurethral resection of the prostate syndrome: almost gone but not forgotten. Journal of Endourology 2009;23(12):2013-20. [PUBMED: 19821694]
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327(7414):557-60. [PUBMED: 12958120]
24. Higgins JPT, Altman DG (editors) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org, [updated September 2009].
25. Issa MM. Technological advances in transurethral resection of the prostate: bipolar versus monopolar TURP. Journal of Endourology 2008;22(8):1587-95. [PUBMED: 18721041]
26. Kirby RS, Kirby M, Fitzpatrick JM. Benign prostatic hyperplasia: counting the cost of its management. British Journal of Urology International 2010;105(7):901-2. [PUBMED: 20356323]
27. Kong CH, Ibrahim MF, Zainuddin ZM. A prospective, randomized clinical trial comparing bipolar plasma kinetic resection of the prostate versus conventional monopolar transurethral resection of the prostate in the treatment of benign prostatic hyperplasia. Annals of Saudi Medicine 2009;29(6):429-32. [PUBMED: 19847078]
28. Lourenco T, Armstrong N, N'Dow J, Nabi G, Deverill M, Pickard R, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technology Assessment (Winchester, England) 2008;12(35):iii, ix-x, 1-146, 169-515. [PUBMED: 19032882]
29. Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, et al. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. British Medical Journal 2008;337:a449. [PUBMED: 18595932]
30. Lourenco T, Pickard R, Vale L, Grant A, Fraser C, MacLennan G, et al. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. British Medical Journal 2008;337:a1662. [PUBMED: 18845591]
31. Mamoulakis C, Trompetter M, de la Rosette J. Bipolar transurethral resection of the prostate: the 'golden standard' reclaims its leading position. Current Opinion in Urology 2009;19(1):26-32. [PUBMED: 19057207]
32. Mamoulakis C, Ubbink DT, de la Rosette JJ. Bipolar versus monopolar transurethral resection of the prostate: a systematic review and meta-analysis of randomized controlled trials. European Urology 2009;56(5):798-809. [PUBMED: 19595501]
33. Mamoulakis C, de la Rosette JJ, Ubbink DT. Re: Burke et al.: systematic review and meta-analysis of transurethral resection of the prostate versus minimally invasive procedures for the treatment of benign prostatic obstruction (Urology 2010;75: 1015-1022). Urology 2010; Vol. 75, issue 5:1235-6; author reply 1236-7. [PUBMED: 20451750]
34. Mamoulakis C, Skolarikos A, Schulze M, Scoffone C, Rassweiler J, Alivizatos G, et al. Results from an international multicentre double-blind randomized controlled trial on perioperative efficacy and safety of bipolar versus monopolar transurethral resection of the prostate. British Journal of Urology International 9 May 2011 [Epub ahead of print]. [PUBMED: 21557796]
35. Michielsen DP, Coomans D. Urethral strictures and bipolar transurethral resection in saline of the prostate: fact or fiction?. Journal of Endourology 2010;24(8):1333-7. [PUBMED: 20583960]
36. Michielsen DP, Coomans D, Braeckman JG, Umbrain V. Bipolar transurethral resection in saline: the solution to avoid hyponatraemia and transurethral resection syndrome. Scandinavian Journal of Urology and Nephrology 2010;44(4):228-35. [PUBMED: 20345336]
37. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. European Urology 2006;50(5):969-79; discussion 980. [PUBMED: 16469429]
38. Rassweiler J, Schulze M, Stock C, Teber D, De La Rosette J. Bipolar transurethral resection of the prostate - technical modifications and early clinical experience. Minimally Invasive Therapy and Allied Technologies 2007;16(1):11-21. [PUBMED: 17365673]
39. Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. European Urology 2006;49(6):970-8; discussion 978. [PUBMED: 16481092]
40. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, et al.Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10, 654 patients. The Journal of Urology 2008;180(1):246-9. [PUBMED: 18499179]
41. Reich O. Bipolar transurethral resection of the prostate: what did we learn, and where do we go from here?. European Urology 2009; Vol. 56, issue 5:796-7. [PUBMED: 19660854]
42. Singhania P, Nandini D, Sarita F, Hemant P, Hemalata I. Transurethral resection of prostate: a comparison of standard monopolar versus bipolar saline resection. International Brazilian Journal of Urology 2010;36(2):183-9. [PUBMED: 20450503]
43. Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. European Urology 2002;42(4):323-8. [PUBMED: 12361895]
44. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. The Journal of Urology 2008;179(5 Suppl):S75-80. [PUBMED: 18405761]